DJIA 16,408.54 -16.31 -0.10%
NASDAQ 4,095.52 0.00 0.00%
S&P 500 1,864.85 2.54 0.14%
market minute promo

Cubist Pharmaceuticals

NASDAQ: CBST

63.95 0.02 (0.03%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CBST $63.95 0.03%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $63.72
Previous Close $63.93
Daily Range $63.04 - $65.32
52-Week Range $44.25 - $82.12
Market Cap $4.8B
P/E Ratio -236.85
Dividend (Yield) $0.00 (0.0%)
Volume 788,764
Average Daily Volume 846,119
Current FY EPS $1.85

Sector

Healthcare

Industry

Drugs

Cubist Pharmaceuticals (CBST) Description

A biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. Website: http://www.cubist.com/

News & Commentary Rss Feed

This Week in Biotech

Two key FDA actions, two positive late-stage clinical trials, and a late-week billion-dollar merger are among this week's top biotech stories.

Jefferies Stocks to Buy That Could Jump From an Earnings Surprise

Will Johnson & Johnson (JNJ) Miss This Earnings Season? - Analyst Blog

Biotech Stock Roundup: MannKind Soars on Panel Vote, Halozyme Plunges on Safety Concerns - Analyst B

Biotech Stock Roundup: MannKind Soars on Panel Vote, Halozyme Plunges on Safety Concerns - Analyst Blog

Cubist Pharmaceuticals (CBST) Marked As Today's Roof Leaker Stock

CBST Crosses Below Key Moving Average Level

Biotech Stock Roundup: Biogen Drug Approved, Exelixis Tumbles on Study Update - Analyst Blog

Durata Therapeutics: Gains Ahead

Tetraphase Antibiotic Nearing Key Tolerability Test

Cubist Rises on Favorable FDA Panel View - Analyst Blog

Biotech Stock Roundup: GILD Letter Triggers Major Selloff - Analyst Blog

Biotech Stock Roundup: GILD Letter Triggers Major Selloff - Analyst Blog

See More CBST News...

CBST's Top Competitors

CBST $63.95 (0.03%)
Current stock: CBST
AMGN $115.46 (-0.07%)
Current stock: AMGN
GILD $70.00 (1.04%)
Current stock: GILD
BIIB $290.54 (-0.32%)
Current stock: BIIB